Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Efficacy of Memantine on Functional Communication in Patients With Alzheimer's Disease (AD)

NCT00469456 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.

NCT NCT00469456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00469456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Efficacy of Memantine on Functional Communication in Patients With Alzheimer's Disease (AD)
Lead sponsor
Forest Laboratories
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2007
Completion date
November 30, 2008
Enrollment
265 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease